Cancer drug price cuts are happening now, with reductions up to 70%. Find out how this impacts patients and the pharma industry.
Hanmi shares obesity drug approval has led to a sharp reversal. What does this mean for investors?
Novo Nordisk weight loss drugs are seeing price cuts. Discover how this impacts accessibility and effectiveness for consumers.
Capricor DMD therapy faces challenges as the company launches a legal fight ahead of the FDA review.
